Clinical trial
The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in IBS
NCT01483287 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in IBS
- Lead sponsor
- Sahlgrenska University Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- August 31, 2013
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.